This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Li Sha - Innovator in Cancer Treatment
Introduction
Li Sha is an innovative inventor based in Gaithersburg, MD (US). She is focused on developing new therapeutic approaches for cancer treatment. Her work is particularly significant in the field of medicinal chemistry, where she explores novel compounds that can inhibit specific kinases involved in cancer progression.
Latest Patent Applications
Li Sha has submitted a patent application titled "SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER." This application discloses certain substituted pyrazine-2-carboxamides of Formula (I), along with their pharmaceutically acceptable salts. The compounds are designed to act as inhibitors of hematopoietic progenitor kinase 1 (HPK1), making them particularly useful in the treatment or prophylaxis of cancer.
Conclusion
Li Sha's contributions to cancer research through her innovative patent application highlight her commitment to advancing therapeutic options for patients. Her work exemplifies the importance of continued research and development in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile